

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * innate immune response in mucosa (GO:0002227) | 9.87895726 |
| 2 | * defense response to fungus (GO:0050832) | 9.77757278 |
| 3 | * antimicrobial humoral response (GO:0019730) | 9.51331398 |
| 4 | * disruption of cells of other organism (GO:0044364) | 9.46858351 |
| 5 | * killing of cells of other organism (GO:0031640) | 9.46858351 |
| 6 | * mucosal immune response (GO:0002385) | 8.06631871 |
| 7 | oxygen transport (GO:0015671) | 7.81756891 |
| 8 | response to peptidoglycan (GO:0032494) | 7.68231764 |
| 9 | * organ or tissue specific immune response (GO:0002251) | 7.57928774 |
| 10 | protoporphyrinogen IX metabolic process (GO:0046501) | 7.26322253 |
| 11 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 7.25266788 |
| 12 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 7.25266788 |
| 13 | * response to fungus (GO:0009620) | 7.21542153 |
| 14 | detection of other organism (GO:0098543) | 7.00833118 |
| 15 | detection of bacterium (GO:0016045) | 6.97924800 |
| 16 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 6.85911027 |
| 17 | cellular extravasation (GO:0045123) | 6.73639110 |
| 18 | hemoglobin metabolic process (GO:0020027) | 6.68936029 |
| 19 | gas transport (GO:0015669) | 6.59285494 |
| 20 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.93949632 |
| 21 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.76806501 |
| 22 | negative regulation of interleukin-8 production (GO:0032717) | 5.53480456 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 5.47154303 |
| 24 | neutrophil activation (GO:0042119) | 5.25782441 |
| 25 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.24374396 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.02139700 |
| 27 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.94377446 |
| 28 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.93695190 |
| 29 | regulation of growth of symbiont in host (GO:0044126) | 4.93695190 |
| 30 | negative regulation of growth of symbiont in host (GO:0044130) | 4.93695190 |
| 31 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.93695190 |
| 32 | * cell killing (GO:0001906) | 4.92681192 |
| 33 | * defense response to Gram-positive bacterium (GO:0050830) | 4.84991969 |
| 34 | granulocyte activation (GO:0036230) | 4.81637073 |
| 35 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 4.63763412 |
| 36 | detection of external biotic stimulus (GO:0098581) | 4.58312821 |
| 37 | leukocyte aggregation (GO:0070486) | 4.47408324 |
| 38 | detection of biotic stimulus (GO:0009595) | 4.36210612 |
| 39 | heme biosynthetic process (GO:0006783) | 4.28108741 |
| 40 | tetrapyrrole biosynthetic process (GO:0033014) | 4.27708775 |
| 41 | superoxide anion generation (GO:0042554) | 4.25644607 |
| 42 | erythrocyte maturation (GO:0043249) | 4.10944653 |
| 43 | regulation of natural killer cell differentiation (GO:0032823) | 4.10241116 |
| 44 | response to host immune response (GO:0052572) | 4.08156865 |
| 45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.08156865 |
| 46 | erythrocyte development (GO:0048821) | 4.00622890 |
| 47 | response to methylmercury (GO:0051597) | 4.00207955 |
| 48 | myeloid cell development (GO:0061515) | 3.90896784 |
| 49 | neutrophil mediated immunity (GO:0002446) | 3.87668718 |
| 50 | negative regulation of interleukin-6 production (GO:0032715) | 3.86223655 |
| 51 | porphyrin-containing compound metabolic process (GO:0006778) | 3.84187561 |
| 52 | * defense response to bacterium (GO:0042742) | 3.81659013 |
| 53 | respiratory burst (GO:0045730) | 3.74760190 |
| 54 | * intracellular estrogen receptor signaling pathway (GO:0030520) | 3.71851513 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.68390200 |
| 56 | response to host (GO:0075136) | 3.68390200 |
| 57 | response to host defenses (GO:0052200) | 3.68390200 |
| 58 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.67223967 |
| 59 | imidazole-containing compound metabolic process (GO:0052803) | 3.55646101 |
| 60 | hydrogen peroxide catabolic process (GO:0042744) | 3.52704076 |
| 61 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.51714769 |
| 62 | regulation of mast cell degranulation (GO:0043304) | 3.43053709 |
| 63 | citrulline biosynthetic process (GO:0019240) | 3.42436870 |
| 64 | heme metabolic process (GO:0042168) | 3.38535392 |
| 65 | * response to bacterium (GO:0009617) | 3.38240943 |
| 66 | positive regulation of osteoblast proliferation (GO:0033690) | 3.18014122 |
| 67 | regulation of leukocyte degranulation (GO:0043300) | 3.16597500 |
| 68 | phagosome maturation (GO:0090382) | 3.15755005 |
| 69 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.14730721 |
| 70 | leukocyte degranulation (GO:0043299) | 3.14420143 |
| 71 | activated T cell proliferation (GO:0050798) | 3.13625236 |
| 72 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.13256098 |
| 73 | neutrophil chemotaxis (GO:0030593) | 3.10969793 |
| 74 | megakaryocyte development (GO:0035855) | 3.10074131 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.08341623 |
| 76 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.06781772 |
| 77 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.03954397 |
| 78 | neutrophil migration (GO:1990266) | 3.03210794 |
| 79 | * modification of morphology or physiology of other organism (GO:0035821) | 3.01327035 |
| 80 | regulation of mast cell activation (GO:0033003) | 2.99088507 |
| 81 | response to muramyl dipeptide (GO:0032495) | 2.96693379 |
| 82 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93959565 |
| 83 | regulation of response to osmotic stress (GO:0047484) | 2.92784470 |
| 84 | myeloid leukocyte mediated immunity (GO:0002444) | 2.89517214 |
| 85 | regulation of regulated secretory pathway (GO:1903305) | 2.87356830 |
| 86 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.83162318 |
| 87 | regulation of female gonad development (GO:2000194) | 2.81802392 |
| 88 | regulation of erythrocyte differentiation (GO:0045646) | 2.79230628 |
| 89 | cellular response to interleukin-6 (GO:0071354) | 2.76726280 |
| 90 | leukotriene biosynthetic process (GO:0019370) | 2.76501365 |
| 91 | leukotriene metabolic process (GO:0006691) | 2.75138621 |
| 92 | granulocyte migration (GO:0097530) | 2.73280753 |
| 93 | positive regulation of granulocyte differentiation (GO:0030854) | 2.68577004 |
| 94 | positive regulation of mast cell activation (GO:0033005) | 2.68393783 |
| 95 | positive regulation of B cell differentiation (GO:0045579) | 2.68312921 |
| 96 | mast cell activation (GO:0045576) | 2.66565369 |
| 97 | pentose-phosphate shunt (GO:0006098) | 2.65664125 |
| 98 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.64465031 |
| 99 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.63006072 |
| 100 | * antibacterial humoral response (GO:0019731) | 10.2713814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.46727448 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.28013099 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 4.01576684 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.87167790 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.82934914 |
| 6 | GATA1_19941826_ChIP-Seq_K562_Human | 3.74413412 |
| 7 | VDR_24763502_ChIP-Seq_THP-1_Human | 3.65603393 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.50153415 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17004696 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.74894105 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72360812 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.70574781 |
| 13 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.69124282 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62531972 |
| 15 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.62513235 |
| 16 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.48826833 |
| 17 | GATA2_19941826_ChIP-Seq_K562_Human | 2.44955063 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41100227 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.38872120 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.37774073 |
| 21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.35994234 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.35427583 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.34625181 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.32814031 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.30260264 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 2.17290150 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.16656681 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.13076195 |
| 29 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.04737010 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.03354387 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01853055 |
| 32 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.93185999 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.92298782 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92185454 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.90707531 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.89615200 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.88939615 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.87934918 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.84957092 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.83351901 |
| 41 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.80704704 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77054810 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.75717951 |
| 44 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.75320165 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73773180 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.72411204 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.70250910 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69085948 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.66436627 |
| 50 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.65290682 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.64665125 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61066503 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.59535704 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58056660 |
| 55 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.56375961 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53889023 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.48693980 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.48511847 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48159507 |
| 60 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.44837346 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41499504 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.39544725 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39066948 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38112055 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37711217 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.35651197 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35397435 |
| 68 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.35011504 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31044132 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27766053 |
| 71 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25690515 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23182402 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22601634 |
| 74 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21094145 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.18574214 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16969304 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14129294 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13353308 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13071390 |
| 80 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.10868299 |
| 81 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10678476 |
| 82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09628316 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06699447 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06489804 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06347714 |
| 86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04687819 |
| 87 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04610344 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02462783 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00417088 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00080630 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97018997 |
| 92 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96331931 |
| 93 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.96151443 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 0.95177677 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93406916 |
| 96 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.91466039 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90602096 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90295336 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88839447 |
| 100 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.87896270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 5.48208320 |
| 2 | MP0004147_increased_porphyrin_level | 5.14696574 |
| 3 | MP0003303_peritoneal_inflammation | 4.71674486 |
| 4 | MP0003436_decreased_susceptibility_to | 3.66029884 |
| 5 | MP0009785_altered_susceptibility_to | 3.43844960 |
| 6 | MP0009278_abnormal_bone_marrow | 3.41955492 |
| 7 | MP0002419_abnormal_innate_immunity | 3.16391527 |
| 8 | MP0005025_abnormal_response_to | 3.09064647 |
| 9 | MP0001545_abnormal_hematopoietic_system | 2.74333909 |
| 10 | MP0005397_hematopoietic_system_phenotyp | 2.74333909 |
| 11 | MP0005083_abnormal_biliary_tract | 2.63355958 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.54754835 |
| 13 | MP0003724_increased_susceptibility_to | 2.41187847 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.32841719 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.24954907 |
| 16 | MP0003828_pulmonary_edema | 2.19429741 |
| 17 | MP0000685_abnormal_immune_system | 2.14687011 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.02970876 |
| 19 | MP0001819_abnormal_immune_cell | 1.99414343 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.98489248 |
| 21 | MP0008260_abnormal_autophagy | 1.89921111 |
| 22 | MP0002398_abnormal_bone_marrow | 1.89744377 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.78669043 |
| 24 | MP0005387_immune_system_phenotype | 1.75803346 |
| 25 | MP0001790_abnormal_immune_system | 1.75803346 |
| 26 | MP0001800_abnormal_humoral_immune | 1.73552309 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.73177753 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.70221353 |
| 29 | MP0002405_respiratory_system_inflammati | 1.68365146 |
| 30 | MP0002723_abnormal_immune_serum | 1.67796830 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.67548132 |
| 32 | MP0002722_abnormal_immune_system | 1.65815808 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.64882311 |
| 34 | MP0002009_preneoplasia | 1.62728706 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.62427113 |
| 36 | MP0001851_eye_inflammation | 1.61128071 |
| 37 | MP0003045_fibrosis | 1.60730144 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.60081190 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.59747405 |
| 40 | MP0003075_altered_response_to | 1.55437372 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.54660172 |
| 42 | MP0000716_abnormal_immune_system | 1.54246050 |
| 43 | MP0009764_decreased_sensitivity_to | 1.54208538 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.52137176 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.51977796 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.51039730 |
| 47 | MP0002429_abnormal_blood_cell | 1.48877257 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.48530009 |
| 49 | MP0002132_abnormal_respiratory_system | 1.46852352 |
| 50 | MP0004947_skin_inflammation | 1.45767940 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.40093696 |
| 52 | MP0002396_abnormal_hematopoietic_system | 1.37152259 |
| 53 | MP0006082_CNS_inflammation | 1.36164604 |
| 54 | MP0005671_abnormal_response_to | 1.23775748 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.22804198 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.14475805 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.12885359 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.05800012 |
| 59 | MP0001853_heart_inflammation | 1.04722642 |
| 60 | MP0005164_abnormal_response_to | 1.04282771 |
| 61 | MP0008469_abnormal_protein_level | 1.04044465 |
| 62 | MP0004883_abnormal_blood_vessel | 1.01539815 |
| 63 | MP0003566_abnormal_cell_adhesion | 0.97497883 |
| 64 | MP0009765_abnormal_xenobiotic_induced | 0.96454204 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 0.96317790 |
| 66 | MP0009931_abnormal_skin_appearance | 0.95175558 |
| 67 | MP0009763_increased_sensitivity_to | 0.92644861 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90073399 |
| 69 | MP0002006_tumorigenesis | 0.87973255 |
| 70 | MP0000858_altered_metastatic_potential | 0.87865749 |
| 71 | MP0001663_abnormal_digestive_system | 0.87459910 |
| 72 | MP0000343_altered_response_to | 0.85979655 |
| 73 | MP0005166_decreased_susceptibility_to | 0.81656697 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.80056080 |
| 75 | MP0000609_abnormal_liver_physiology | 0.72860910 |
| 76 | MP0003795_abnormal_bone_structure | 0.72845633 |
| 77 | MP0004130_abnormal_muscle_cell | 0.69346393 |
| 78 | MP0004510_myositis | 0.68096840 |
| 79 | MP0005390_skeleton_phenotype | 0.66074050 |
| 80 | MP0000249_abnormal_blood_vessel | 0.64848483 |
| 81 | MP0003866_abnormal_defecation | 0.62124412 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.59995235 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.59956625 |
| 84 | MP0008004_abnormal_stomach_pH | 0.58693560 |
| 85 | MP0003448_altered_tumor_morphology | 0.58143381 |
| 86 | MP0000604_amyloidosis | 0.57086900 |
| 87 | MP0004381_abnormal_hair_follicle | 0.56819789 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.56431065 |
| 89 | MP0000598_abnormal_liver_morphology | 0.55511623 |
| 90 | MP0005621_abnormal_cell_physiology | 0.55489947 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.55402738 |
| 92 | MP0002095_abnormal_skin_pigmentation | 0.54605192 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.54558947 |
| 94 | MP0003690_abnormal_glial_cell | 0.54218456 |
| 95 | MP0000490_abnormal_crypts_of | 0.53981947 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.53902193 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.53135512 |
| 98 | MP0009115_abnormal_fat_cell | 0.53001953 |
| 99 | MP0004264_abnormal_extraembryonic_tissu | 0.52687824 |
| 100 | MP0005535_abnormal_body_temperature | 0.52344265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic anemia (HP:0001931) | 6.68086609 |
| 2 | Poikilocytosis (HP:0004447) | 6.20484988 |
| 3 | Microcytic anemia (HP:0001935) | 5.63715643 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.07236234 |
| 5 | Recurrent abscess formation (HP:0002722) | 5.06959339 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.04690557 |
| 7 | Polycythemia (HP:0001901) | 4.82567088 |
| 8 | Abnormal hemoglobin (HP:0011902) | 4.81295123 |
| 9 | Stomatitis (HP:0010280) | 4.25063787 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.17386845 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.12305702 |
| 12 | Cholelithiasis (HP:0001081) | 4.06475240 |
| 13 | Prolonged bleeding time (HP:0003010) | 3.97673043 |
| 14 | Toxemia of pregnancy (HP:0100603) | 3.94753196 |
| 15 | Paralysis (HP:0003470) | 3.86676894 |
| 16 | Abnormal gallbladder morphology (HP:0012437) | 3.64063467 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.62080515 |
| 18 | Obstructive lung disease (HP:0006536) | 3.62080515 |
| 19 | Abnormality of iron homeostasis (HP:0011031) | 3.59123903 |
| 20 | Reticulocytosis (HP:0001923) | 3.40906137 |
| 21 | Urticaria (HP:0001025) | 3.36393711 |
| 22 | Diaphragmatic weakness (HP:0009113) | 3.30375733 |
| 23 | Myositis (HP:0100614) | 3.23409897 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.17306304 |
| 25 | Recurrent skin infections (HP:0001581) | 3.10515303 |
| 26 | Epistaxis (HP:0000421) | 3.09717369 |
| 27 | Petechiae (HP:0000967) | 3.09232995 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.07094887 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.06083954 |
| 30 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.01174891 |
| 31 | Abnormal platelet volume (HP:0011876) | 2.99375144 |
| 32 | Recurrent fungal infections (HP:0002841) | 2.99337506 |
| 33 | Gingivitis (HP:0000230) | 2.97766266 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 2.95271680 |
| 35 | Acanthocytosis (HP:0001927) | 2.87747705 |
| 36 | Meningitis (HP:0001287) | 2.86873381 |
| 37 | Amyloidosis (HP:0011034) | 2.84778227 |
| 38 | Osteomyelitis (HP:0002754) | 2.84147857 |
| 39 | Cellulitis (HP:0100658) | 2.71355514 |
| 40 | Systemic lupus erythematosus (HP:0002725) | 2.66675325 |
| 41 | Abnormality of the gallbladder (HP:0005264) | 2.63099409 |
| 42 | Abnormality of the fingertips (HP:0001211) | 2.59124388 |
| 43 | Increased mean platelet volume (HP:0011877) | 2.58965016 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.55351958 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.55351958 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.48077990 |
| 47 | Increased serum ferritin (HP:0003281) | 2.47919622 |
| 48 | Episodic fever (HP:0001954) | 2.47444173 |
| 49 | Gingival bleeding (HP:0000225) | 2.47257694 |
| 50 | Increased IgE level (HP:0003212) | 2.47160834 |
| 51 | Orchitis (HP:0100796) | 2.42658283 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 2.39068970 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.37888228 |
| 54 | Optic neuritis (HP:0100653) | 2.34094610 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.34094610 |
| 56 | Recurrent viral infections (HP:0004429) | 2.33630392 |
| 57 | Anorexia (HP:0002039) | 2.32040211 |
| 58 | Granulocytopenia (HP:0001913) | 2.30368464 |
| 59 | Ileus (HP:0002595) | 2.27890310 |
| 60 | Hepatosplenomegaly (HP:0001433) | 2.26910658 |
| 61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.22183569 |
| 62 | Pustule (HP:0200039) | 2.21453776 |
| 63 | Vasculitis (HP:0002633) | 2.20757039 |
| 64 | Abnormality of reticulocytes (HP:0004312) | 2.19877542 |
| 65 | Thrombophlebitis (HP:0004418) | 2.19563448 |
| 66 | Leukocytosis (HP:0001974) | 2.18851688 |
| 67 | Keratoconjunctivitis (HP:0001096) | 2.15558267 |
| 68 | Abnormal platelet function (HP:0011869) | 2.12012548 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.12012548 |
| 70 | Cutaneous photosensitivity (HP:0000992) | 2.11118570 |
| 71 | Menorrhagia (HP:0000132) | 2.10297337 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.08107772 |
| 73 | Cholecystitis (HP:0001082) | 2.08107772 |
| 74 | Encephalitis (HP:0002383) | 2.03317814 |
| 75 | Pallor (HP:0000980) | 2.03308608 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 11.5041261 |
| 77 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 10.4905018 |
| 78 | Spontaneous hematomas (HP:0007420) | 1.98644919 |
| 79 | Hyperbilirubinemia (HP:0002904) | 1.96993757 |
| 80 | Hypertensive crisis (HP:0100735) | 1.96956405 |
| 81 | Hemoptysis (HP:0002105) | 1.96750536 |
| 82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95252353 |
| 83 | Pulmonary infiltrates (HP:0002113) | 1.95195909 |
| 84 | Paresthesia (HP:0003401) | 1.94586420 |
| 85 | Purpura (HP:0000979) | 1.93506393 |
| 86 | Chest pain (HP:0100749) | 1.93361282 |
| 87 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.88505652 |
| 88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88505652 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 1.88505652 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 1.84127553 |
| 91 | Skin rash (HP:0000988) | 1.83450376 |
| 92 | Inflammation of the large intestine (HP:0002037) | 1.81825803 |
| 93 | Colitis (HP:0002583) | 1.80430010 |
| 94 | Difficulty running (HP:0009046) | 1.78635313 |
| 95 | Abnormality of B cell number (HP:0010975) | 1.78057743 |
| 96 | Hypertriglyceridemia (HP:0002155) | 1.76479495 |
| 97 | Abnormality of the pericardium (HP:0001697) | 1.76230487 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.75164303 |
| 99 | Slow saccadic eye movements (HP:0000514) | 1.75064950 |
| 100 | Nausea (HP:0002018) | 1.74872947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 5.02731629 |
| 2 | MAP2K3 | 4.97110445 |
| 3 | RIPK4 | 4.01806314 |
| 4 | GRK6 | 3.48436928 |
| 5 | TAOK1 | 2.95512371 |
| 6 | MAP3K3 | 2.66830061 |
| 7 | TAOK2 | 2.64746447 |
| 8 | BLK | 2.27477138 |
| 9 | FES | 2.26180164 |
| 10 | MAP3K11 | 2.25714033 |
| 11 | IRAK4 | 2.15157090 |
| 12 | MAP3K6 | 2.08014010 |
| 13 | TNK2 | 2.03239175 |
| 14 | ZAP70 | 1.98045147 |
| 15 | SYK | 1.91567612 |
| 16 | TEC | 1.87763106 |
| 17 | BTK | 1.86625128 |
| 18 | MAP4K1 | 1.85232177 |
| 19 | PIK3CG | 1.80121015 |
| 20 | ERN1 | 1.73559358 |
| 21 | TYK2 | 1.69434779 |
| 22 | FGR | 1.59236291 |
| 23 | MAP3K1 | 1.30867157 |
| 24 | HCK | 1.21170272 |
| 25 | CSK | 1.18466551 |
| 26 | MAP3K14 | 1.16260041 |
| 27 | MAPK12 | 1.16060361 |
| 28 | LYN | 1.15814439 |
| 29 | MAP3K5 | 1.13552869 |
| 30 | JAK2 | 1.12710631 |
| 31 | EIF2AK1 | 1.12513748 |
| 32 | MAP3K13 | 1.07685516 |
| 33 | EPHB1 | 1.07574604 |
| 34 | IRAK1 | 1.03872504 |
| 35 | KSR2 | 1.02419603 |
| 36 | CAMK1D | 1.00848375 |
| 37 | CLK1 | 1.00554539 |
| 38 | TRPM7 | 1.00105932 |
| 39 | PDK2 | 0.98660015 |
| 40 | PTK2B | 0.98656424 |
| 41 | MARK3 | 0.96586185 |
| 42 | TRIB3 | 0.94266687 |
| 43 | MAP2K4 | 0.92395605 |
| 44 | ITK | 0.90455648 |
| 45 | CDK12 | 0.88927327 |
| 46 | IKBKE | 0.88784255 |
| 47 | MAPK7 | 0.87860690 |
| 48 | TXK | 0.85253003 |
| 49 | TESK2 | 0.85174216 |
| 50 | IRAK2 | 0.80031677 |
| 51 | DAPK2 | 0.77897087 |
| 52 | YES1 | 0.75642238 |
| 53 | PDPK1 | 0.73609756 |
| 54 | MARK2 | 0.72992328 |
| 55 | TBK1 | 0.72329736 |
| 56 | PIK3CA | 0.72258616 |
| 57 | BMPR2 | 0.69739562 |
| 58 | KIT | 0.67287439 |
| 59 | PDK1 | 0.66072394 |
| 60 | LCK | 0.65323535 |
| 61 | HIPK2 | 0.64562066 |
| 62 | PIM1 | 0.64020836 |
| 63 | RET | 0.63982641 |
| 64 | RPS6KL1 | 0.63627835 |
| 65 | RPS6KC1 | 0.63627835 |
| 66 | JAK1 | 0.59498411 |
| 67 | JAK3 | 0.58963193 |
| 68 | EPHA3 | 0.56597585 |
| 69 | BMX | 0.56333990 |
| 70 | IKBKB | 0.53939580 |
| 71 | CDK6 | 0.52817505 |
| 72 | TTN | 0.52047630 |
| 73 | RPS6KA6 | 0.51738593 |
| 74 | CAMK1G | 0.51595205 |
| 75 | KSR1 | 0.51512339 |
| 76 | MAPK4 | 0.50808037 |
| 77 | SGK3 | 0.49572658 |
| 78 | SMG1 | 0.49538854 |
| 79 | MAP2K2 | 0.48356379 |
| 80 | MAP2K1 | 0.46842009 |
| 81 | MAP2K6 | 0.46530495 |
| 82 | STK11 | 0.45404075 |
| 83 | PTK6 | 0.43789438 |
| 84 | STK10 | 0.43027637 |
| 85 | FYN | 0.41956108 |
| 86 | SIK3 | 0.41358797 |
| 87 | MAP3K7 | 0.40840699 |
| 88 | PRKAA2 | 0.40235618 |
| 89 | WNK1 | 0.39280719 |
| 90 | RAF1 | 0.39173592 |
| 91 | TGFBR2 | 0.37970139 |
| 92 | MAP3K8 | 0.37858980 |
| 93 | CDK19 | 0.37721297 |
| 94 | STK4 | 0.36990837 |
| 95 | RPS6KA2 | 0.36405912 |
| 96 | PRKCQ | 0.34701005 |
| 97 | SIK2 | 0.34055326 |
| 98 | SGK2 | 0.33928711 |
| 99 | IRAK3 | 0.32324281 |
| 100 | PRKD2 | 0.31971433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.58197544 |
| 2 | Malaria_Homo sapiens_hsa05144 | 3.64233299 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.74230142 |
| 4 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.71720558 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44460565 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.28348619 |
| 7 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.17956042 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.10540127 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.87404709 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 1.84031131 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74444253 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74305017 |
| 13 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.73076919 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.69942997 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62563788 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61381290 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.60220369 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.50894953 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.48751773 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44299300 |
| 21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36665437 |
| 22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35630261 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32335913 |
| 24 | Platelet activation_Homo sapiens_hsa04611 | 1.31742334 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28881495 |
| 26 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.26874208 |
| 27 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.26017481 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.21068128 |
| 29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.19936697 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18909385 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.18000140 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.17455232 |
| 33 | Amoebiasis_Homo sapiens_hsa05146 | 1.13920434 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10656989 |
| 35 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10074183 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08142296 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07331112 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06050598 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05029724 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.04236704 |
| 41 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.01982007 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00112184 |
| 43 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.99731988 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99700012 |
| 45 | Measles_Homo sapiens_hsa05162 | 0.99073709 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97483862 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96735583 |
| 48 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.96314008 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95912140 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.95582975 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91509842 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 0.88673422 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87755254 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87179365 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86696760 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86560862 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.85166841 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.81557214 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80398154 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79875072 |
| 61 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78824603 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76880104 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76493447 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76402108 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.75497809 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74455779 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.73765860 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73172474 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71777359 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70217466 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69096387 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67316983 |
| 73 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64859527 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.63369023 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62856500 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.62525223 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60328078 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60193525 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59957795 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58094701 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57021676 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55088105 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.54750634 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52465494 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.51773640 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51150646 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49909535 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 0.49699771 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49494457 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48045254 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47209303 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46373376 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44850770 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44836593 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44311443 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43885681 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43596310 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.42588631 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41693071 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.40299758 |

